Research data show that weight regain after discontinuation of GLP-1 or GLP-1/GIP agonists is a significant risk.
Maryam Akintoye, PharmD Candidate
Advertisement
Articles by Maryam Akintoye, PharmD Candidate
Pharmacists play an important role in managing patients with this complex condition.
Advertisement
Latest Updated Articles
Are the Weight Loss Effects of Tirzepatide and Semaglutide Temporary?Published: January 29th 2026 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
Enlicitide Meaningfully Lowers LDL-C at 24 Weeks in Patients At Risk for ASCVD Events
3
Evaluating Pharmacists’ Role In Veterinary Medication Management and Education
4
SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury
5